@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:10158
  skos:prefLabel "agentes antinflamatorios no esteroidales"@es, "nonsteroidal anti-inflammatory agents"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:narrower nalt:21165407 .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:21165407
  skos:definition nalt:21165407_def ;
  skos:prefLabel "mavacoxib"@es, "Mavacoxib"@en ;
  skos:inScheme <https://lod.nal.usda.gov/nalt-awic>, <https://lod.nal.usda.gov/nalt> ;
  skos:broader nalt:10158 ;
  dc:modified "2024-05-04"^^xsd:date ;
  dc:created "2023-04-03"^^xsd:date ;
  a skos:Concept .

nalt:21165407_def
  rdf:value "Mavacoxib is a member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and 4-fluorophenyl groups, respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine to treat pain and inflammation in dogs with degenerative joint disease. It has a role as a non-steroidal anti-inflammatory drug, a cyclooxygenase 2 inhibitor and a non-narcotic analgesic. It is a sulfonamide, an organofluorine compound and a member of pyrazoles."@en, "1H-pirazol sustituido en las posiciones 1, 3 y 5 por los grupos 4-sulfamoilfenilo, trifluorometilo y 4-fluorofenilo, respectivamente. Se trata de una sulfonamida y un compuesto organofluorado. Constituye un inhibidor selectivo de la ciclooxigenasa 2, un antiinflamatorio no esteroideo y un analgésico no narcótico que se utiliza en la medicina veterinaria para tratar el dolor y la inflamación en perros con enfermedades articulares degenerativas. "@es ;
  dc:source "MeSH" ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  a <https://lod.nal.usda.gov/naltv#Definition> .